Skip to main content

Table 5 Subgroup analysis of bupivacaine vs. mepivacaine in same day discharge patients

From: Postoperative outcomes of mepivacaine vs. bupivacaine in patients undergoing total joint arthroplasty with spinal anesthesia

Outcome – n (%) or Avg. ± SD

Total Hip Arthroplasty

Total Knee Arthroplasty

Bupivacaine (n=104)

Mepivacaine (n=141)

P-Value

Bupivacaine (n=59)

Mepivacaine (n=138)

P-Value

Isobaric Bupivacaine

8 (7.7)

0 (0.0)

N/A

4 (6.8)

0 (0.0)

N/A

Ambulated POD0

104 (100.0)

141 (100.0)

N/A

59 (100.0)

138 (100.0)

N/A

First 6-Clicks Mobility Scorea

21.26 ± 2.28

20.16 ± 2.38

0.001

22.08 ± 2.15

19.96 ± 2.54

<0.001

First PT Ambulation Distance (ft)b

193.81 ± 73.84

208.93 ± 66.60

0.144

220.25 ± 90.13

215.53 ± 82.85

0.757

Urinary Retention

1 (1.0)

2 (1.4)

1.000*

1 (1.7)

0 (0.0)

0.299*

Home Discharge

104 (100.0)

141 (100.0)

N/A

59 (100.0)

138 (100.0)

N/A

30-Day Readmission

0 (0.0)

2 (1.4)

0.509*

2 (3.4)

2 (1.4)

0.585*

30-Day ED Return

0 (0.0)

4 (2.8)

0.138*

2 (3.4)

2 (3.6)

1.000*

  1. P-Values <0.05 in bold
  2. POD postoperative day, PT physical therapy, ED emergency department
  3. *Denotes Fisher’s Exact Test
  4. an= THA 91 B, 105 M; TKA 52 B, 103 M
  5. bn= THA 90 B, 96 M; TKA 52 B, 81 M